Eunjin Eom

Eunjin Eom

Auto-generated profile, based on publicly available information

Eunjin Eom

질병관리청 질병데이터과학분석관 역학데이터분석담당

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HHHyukpyo Hong
Hyukpyo Hong
EEEunjin Eom
Eunjin Eom
HLHyojung Lee
Hyojung Lee
SCSunhwa Choi
Sunhwa Choi
BCBoseung Choi
Boseung Choi
JKJae Kyoung Kim
Jae Kyoung Kim
Epidemiological parameters such as the reproduction number, latent period, and infectious period provide crucial information about the spread of infectious diseases and directly inform intervention strategies. These parameters have generally been estimated by mathematical models that involve an unrealistic assumption of history-independent dynamics for simplicity. This assumes that the chance of becoming infectious during the latent period or recovering during the infectious period remains constant, whereas in reality, these chances vary over time. Here, we find that conventional approaches with this assumption cause serious bias in epidemiological parameter estimation. To address this bias, we developed a Bayesian inference method by adopting more realistic history-dependent disease dynamics. Our method more accurately and precisely estimates the reproduction number than the conventional approaches solely from confirmed cases data, which are easy to obtain through testing. It also revealed how the infectious period distribution changed throughout the COVID-19 pandemic during 2020 in South Korea. We also provide a user-friendly package, IONISE, that automates this method.

28 November 2024 in Public Health Weekly Report
Verified
Journal Article
Open access
혜이혜련 이
혜련 이
수최수현 최
수현 최
은엄은진 엄
은진 엄
경송경희 송
경희 송
성김성순 김
성순 김
As part of the effort to establish a scientific basis for quarantine policies aimed at responding to new infectious diseases based on the experience of responding to coronavirus disease 2019 (COVID-19), the Korea Disease Control and Prevention Agency (KDCA) and National Health Insurance Service promoted the establishment of health information big data and signed a business agreement (April 29, 2021). The big data created by combining the KDCA’s COVID-19 confirmed cases and vaccination data with the National Health Insurance Service’s national health information are known as K-COV-N (KDCA Covid-19 NHIS cohort). The big data constructed were opened to the private sector through the National Health Insurance Service’s open platform to promote private research. A cumulative total of 211 cases have been approved since the opening of COVID-19 big data from April 2022 until October 2, 2024, and a total of 30 papers have been published in international journals. The main contents were research results such as COVID-19 infection risk factors, vaccination effects, and long COVID. In addition, after the opening of big data, we held workshops on practical networking for utilizing COVID-19 big data to share analyses and techniques for utilizing the data. Additionally, we established a public-private data analysis network to promote exchanges between practitioners. In addition, we are contributing to the activation of private research by expanding ties with the National Cancer Center and health-information-holding organizations. Accordingly, the KDCA plans to continue opening up infectious disease-related information to develop evidence-based quarantine policies and support expert decision-making.